Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Current Frontiers

A Comprehensive Review of Pharmacokinetics and Pharmacodynamics in Animals: Exploration of Interaction with Antibiotics of Shuang-Huang- Lian Preparations

Author(s): Liuyi Liang, Xin Jin, Jinjing Li, Rong Li, Xinyi Jiao, Yuanyuan Ma , Rui Liu* and Zheng Li *

Volume 22, Issue 2, 2022

Published on: 12 October, 2021

Page: [83 - 94] Pages: 12

DOI: 10.2174/1568026621666211012111442

Price: $65

Abstract

As a traditional Chinese medicine (TCM), Shuang-Huang-Lian (SHL) has been widely used for treating infectious diseases of the respiratory tract such as encephalitis, pneumonia, and asthma. During the past few decades, considerable research has focused on pharmacological action, pharmacokinetic interaction with antibiotics, and clinical applications of SHL. A huge and more recent body of pharmacokinetic studies support the combination of SHL and antibiotics have different effects such as antagonism and synergism. SHL has been one of the best-selling TCM products. However, there is no systematic review of SHL preparations, ranging from protection against respiratory tract infections to interaction with antibiotics. Since their important significance in clinical therapy, the pharmacodynamics, pharmacokinetics, and interactions with antibiotics of SHL were reviewed and discussed. In addition, this review attempts to explore the possible potential mechanism of SHL preparations in the prevention and treatment of COVID-19. We are concerned about the effects of SHL against viruses and bacteria, as well as its interactions with antibiotics in an attempt to provide a new strategy for expanding the clinical research and medication of SHL preparations.

Keywords: Shuang-Huang-Lian preparations, Drug-drug interaction, Pharmacokinetics, Pharmacodynamics, COVID-19, TCM.

« Previous
Graphical Abstract

[1]
Luan, L.; Wang, G.; Lin, R. HPLC and chemometrics for the quality consistency evaluation of Shuanghuanglian injection. J. Chromatogr. Sci., 2014, 52(7), 707-712.
[http://dx.doi.org/10.1093/chromsci/bmt104] [PMID: 23868179]
[2]
Chen, L.; Titch, T.; Luo, Z.; Xu, Y.; Li, X.; Huang, F.; Liu, L.; Xiao, W.; Wu, H.; Wang, Z. Confirmation of a proarrhythmic risk underlying the clinical use of common Chinese herbal intravenous injections. J. Ethnopharmacol., 2012, 142(3), 829-835.
[http://dx.doi.org/10.1016/j.jep.2012.06.008] [PMID: 22721881]
[3]
Li, Y.; Li, W.; Fu, C.; Song, Y.; Fu, Q. Lonicerae japonicae flos and Lonicerae flos: A systematic review of ethnopharmacology, phytochemistry and pharmacology. Phytochem. Rev., 2019, 1-61.
[PMID: 32206048]
[4]
Wang, L.; Jiang, Q.; Hu, J.; Zhang, Y.; Li, J. Research progress on chemical constituents of Lonicerae japonicae flos. BioMed Res. Int., 2016, 2016, 8968940.
[PMID: 27403439]
[5]
Shen, J.; Li, P.; Liu, S.; Liu, Q.; Li, Y.; Sun, Y.; He, C.; Xiao, P. Traditional uses, ten-years research progress on phytochemistry and pharmacology, and clinical studies of the genus Scutellaria. J. Ethnopharmacol., 2021, 265, 113198.
[http://dx.doi.org/10.1016/j.jep.2020.113198] [PMID: 32739568]
[6]
Dong, Z.; Lu, X.; Tong, X.; Dong, Y.; Tang, L.; Liu, M. Forsythiae fructus: A review on its phytochemistry, quality control, pharmacology and pharmacokinetics. Molecules, 2017, 22(9), 1466.
[http://dx.doi.org/10.3390/molecules22091466] [PMID: 28869577]
[7]
Duan, X.; Wang, H.; Wu, J.; Zhou, W.; Wang, K.; Liu, X. Comparative efficacy of Chinese herbal injections for the treatment of herpangina: A bayesian network meta-analysis of randomized controlled trials. Front. Pharmacol., 2020, 11, 693.
[http://dx.doi.org/10.3389/fphar.2020.00693] [PMID: 32477147]
[8]
Han, J.; Zhao, Y.; Zhang, Y.; Li, C.; Yi, Y.; Pan, C.; Tian, J.; Yang, Y.; Cui, H.; Wang, L.; Liu, S.; Liu, J.; Deng, N.; Liang, A. RhoA/ROCK signaling pathway mediates shuanghuanglian injection-induced pseudo-allergic reactions. Front. Pharmacol., 2018, 9, 87.
[http://dx.doi.org/10.3389/fphar.2018.00087] [PMID: 29487527]
[9]
Zhang, J.; Shang, H.; Zheng, W.; Hu, J.; Xu, H.; Wang, H.; Zhang, L.; Ren, M.; Zhang, B. Systematic review on the compatibility of Shuanghuanglian injection combined with western medical injections. J. Evid. Based Med., 2010, 3(1), 27-36.
[http://dx.doi.org/10.1111/j.1756-5391.2010.01068.x] [PMID: 21349037]
[10]
Horby, P.; Lim, W.S.; Emberson, J.R.; Mafham, M.; Bell, J.L.; Linsell, L.; Staplin, N.; Brightling, C.; Ustianowski, A.; Elmahi, E.; Prudon, B.; Green, C.; Felton, T.; Chadwick, D.; Rege, K.; Fegan, C.; Chappell, L.C.; Faust, S.N.; Jaki, T.; Jeffery, K.; Montgomery, A.; Rowan, K.; Juszczak, E.; Baillie, J.K.; Haynes, R.; Landray, M.J. Dexamethasone in hospitalized patients with COVID-19 preliminary report. N. Engl. J. Med., 2021, 384(8), 693-704.
[http://dx.doi.org/10.1056/NEJMoa2021436] [PMID: 32678530]
[11]
Innes, A.J.; Cook, L.B.; Marks, S.; Bataillard, E.; Crossette-Thambiah, C.; Sivasubramaniam, G.; Apperley, J.; Milojkovic, D. Ruxolitinib for tocilizumab-refractory severe COVID-19 infection. Br. J. Haematol., 2020, 190(4), e198-e200.
[http://dx.doi.org/10.1111/bjh.16979] [PMID: 32593183]
[12]
Ren, J.L.; Zhang, A.H.; Wang, X.J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol. Res., 2020, 155, 104743.
[http://dx.doi.org/10.1016/j.phrs.2020.104743] [PMID: 32145402]
[13]
Zhang, F.X.; Xie, Z.N.; Tang, X.Y.; Li, C.; Li, M.; Yao, Z.H.; Dai, Y.; Yao, X.S. A combination of representative compounds, metabolism platform and diagnostic extraction strategy for characterization of metabolites of Shuang-Huang-Lian oral liquid in vivo by ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry. J. Pharm. Biomed. Anal., 2018, 155, 216-234.
[http://dx.doi.org/10.1016/j.jpba.2018.03.066] [PMID: 29655093]
[14]
Zhang, H.; Zhang, S.; Hu, M.; Chen, Y.; Wang, W.; Zhang, K.; Kuang, H.; Wang, Q. An integrative metabolomics and network pharmacology method for exploring the effect and mechanism of Radix Bupleuri and Radix Paeoniae Alba on anti-depression. J. Pharm. Biomed. Anal., 2020, 189, 113435.
[http://dx.doi.org/10.1016/j.jpba.2020.113435] [PMID: 32653815]
[15]
Sun, Y.; Feng, G.; Zheng, Y.; Liu, S.; Zhang, Y.; Pi, Z.; Song, F.; Liu, Z. Putative multiple reaction monitoring strategy for the comparative pharmacokinetics of postoral administration Renshen-Yuanzhi compatibility through liquid chromatography-tandem mass spectrometry. J. Ginseng Res., 2020, 44(1), 105-114.
[http://dx.doi.org/10.1016/j.jgr.2018.09.007] [PMID: 32148393]
[16]
Hou, W.J.; Ceesay, B. Extraction of drug-drug interaction using neural embedding. J. Bioinform. Comput. Biol., 2018, 16(6), 1840027.
[http://dx.doi.org/10.1142/S0219720018400279] [PMID: 30567477]
[17]
Zhou, W.; Zhu, X.X.; Yin, A.L.; Cai, B.C.; Wang, H.D.; Di, L.; Shan, J.J. Effect of various absorption enhancers based on tight junctions on the intestinal absorption of forsythoside A in Shuang-Huang-Lian, application to its antivirus activity. Pharmacogn. Mag., 2014, 10(37), 9-17.
[http://dx.doi.org/10.4103/0973-1296.126651] [PMID: 24695554]
[18]
Subbarao, K.; Klimov, A.; Katz, J.; Regnery, H.; Lim, W.; Hall, H.; Perdue, M.; Swayne, D.; Bender, C.; Huang, J.; Hemphill, M.; Rowe, T.; Shaw, M.; Xu, X.; Fukuda, K.; Cox, N. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 1998, 279(5349), 393-396.
[http://dx.doi.org/10.1126/science.279.5349.393] [PMID: 9430591]
[19]
Claas, E.C.; Osterhaus, A.D.; van Beek, R.; De Jong, J.C.; Rimmelzwaan, G.F.; Senne, D.A.; Krauss, S.; Shortridge, K.F.; Webster, R.G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet, 1998, 351(9101), 472-477.
[http://dx.doi.org/10.1016/S0140-6736(97)11212-0] [PMID: 9482438]
[20]
Lai, S.; Qin, Y.; Cowling, B.J.; Ren, X.; Wardrop, N.A.; Gilbert, M.; Tsang, T.K.; Wu, P.; Feng, L.; Jiang, H.; Peng, Z.; Zheng, J.; Liao, Q.; Li, S.; Horby, P.W.; Farrar, J.J.; Gao, G.F.; Tatem, A.J.; Yu, H. Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997-2015: A systematic review of individual case data. Lancet Infect. Dis., 2016, 16(7), e108-e118.
[http://dx.doi.org/10.1016/S1473-3099(16)00153-5] [PMID: 27211899]
[21]
Wonderlich, E.R.; Swan, Z.D.; Bissel, S.J.; Hartman, A.L.; Carney, J.P.; O’Malley, K.J.; Obadan, A.O.; Santos, J.; Walker, R.; Sturgeon, T.J.; Frye, L.J., Jr; Maiello, P.; Scanga, C.A.; Bowling, J.D.; Bouwer, A.L.; Duangkhae, P.A.; Wiley, C.A.; Flynn, J.L.; Wang, J.; Cole, K.S.; Perez, D.R.; Reed, D.S.; Barratt-Boyes, S.M. Widespread virus replication in alveoli drives acute respiratory distress syndrome in aerosolized H5N1 influenza infection of macaques. J. Immunol., 2017, 198(4), 1616-1626.
[http://dx.doi.org/10.4049/jimmunol.1601770] [PMID: 28062701]
[22]
Li, Y.; Duan, J.; Xia, H.; Shu, B.; Duan, W. Macromolecular substances as a dangerous factor in traditional Chinese medicine injections were determined by size-exclusive chromatography. Toxicol. Res. (Camb.), 2020, 9(3), 323-330.
[http://dx.doi.org/10.1093/toxres/tfaa024] [PMID: 32670563]
[23]
Sun, X.; Zeng, H.; Kumar, A.; Belser, J.A.; Maines, T.R.; Tumpey, T.M. Constitutively expressed IFITM3 protein in human endothelial cells poses an early infection block to human influenza viruses. J. Virol., 2016, 90(24), 11157-11167.
[http://dx.doi.org/10.1128/JVI.01254-16] [PMID: 27707929]
[24]
Tang, Y.; Wang, Z.; Huo, C.; Guo, X.; Yang, G.; Wang, M.; Tian, H.; Hu, Y.; Dong, H. Antiviral effects of Shuanghuanglian injection powder against influenza A virus H5N1 in vitro and in vivo. Microb. Pathog., 2018, 121, 318-324.
[http://dx.doi.org/10.1016/j.micpath.2018.06.004] [PMID: 29864534]
[25]
Xiong, W.; Goverdhana, S.; Sciascia, S.A.; Candolfi, M.; Zirger, J.M.; Barcia, C.; Curtin, J.F.; King, G.D.; Jaita, G.; Liu, C.; Kroeger, K.; Agadjanian, H.; Medina-Kauwe, L.; Palmer, D.; Ng, P.; Lowenstein, P.R.; Castro, M.G. Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses. J. Virol., 2006, 80(1), 27-37.
[http://dx.doi.org/10.1128/JVI.80.1.27-37.2006] [PMID: 16352528]
[26]
Zhang, Q.; Su, X.; Gong, S.; Zeng, Q.; Zhu, B.; Wu, Z.; Peng, T.; Zhang, C.; Zhou, R. Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China. J. Gen. Virol., 2006, 87(Pt 6), 1531-1541.
[http://dx.doi.org/10.1099/vir.0.81515-0] [PMID: 16690917]
[27]
Demian, P.N.; Horton, K.C.; Kajon, A.; Siam, R.; Hasanin, A.M.; Elgohary Sheta, A.; Cornelius, C.; Gaynor, A.M. Molecular identification of adenoviruses associated with respiratory infection in Egypt from 2003 to 2010. BMC Infect. Dis., 2014, 14, 50.
[http://dx.doi.org/10.1186/1471-2334-14-50] [PMID: 24479824]
[28]
Gao, J.; Xu, L.; Xu, B.; Xie, Z.; Shen, K. Human adenovirus Coinfection aggravates the severity of Mycoplasma pneumoniae pneumonia in children. BMC Infect. Dis., 2020, 20(1), 420.
[http://dx.doi.org/10.1186/s12879-020-05152-x] [PMID: 32546135]
[29]
Shi, Y.; Xu, J.; Qiao, Y.; Zhang, W.; Liu, D.; Qin, M.; Liu, G.; Dong, M. Effects of shuanghuanglian injection on the activities of CYP1A2, 2C11, 2D1 and 3A1/2 in rats in vivo and in vitro. Xenobiotica, 2019, 49(8), 905-911.
[http://dx.doi.org/10.1080/00498254.2018.1523487] [PMID: 30231664]
[30]
Ma, Q.; Liang, D.; Song, S.; Yu, Q.; Shi, C.; Xing, X.; Luo, J.B. Comparative study on the antivirus activity of Shuang-huang-lian injectable powder and its bioactive compound mixture against human adenovirus III in vitro. Viruses, 2017, 9(4), 79.
[http://dx.doi.org/10.3390/v9040079] [PMID: 28417913]
[31]
Tan, V.; Thai, H.; Phu, N.H.; Nghia, H.D.; Chuong, L.V.; Sinh, D.X.; Phong, N.D.; Mai, N.T.; Man, D.N.; Hien, V.M.; Vinh, N.T.; Day, J.; Chau, N.V.; Hien, T.T.; Farrar, J.; de Jong, M.D.; Thwaites, G.; van Doorn, H.R.; Chau, T.T. Viral aetiology of central nervous system infections in adults admitted to a tertiary referral hospital in southern Vietnam over 12 years. PLoS Negl. Trop. Dis., 2014, 8(8), e3127.
[http://dx.doi.org/10.1371/journal.pntd.0003127] [PMID: 25165820]
[32]
Gu, N.; Tian, Y.; Di, Z.; Han, C.; Lei, H.; Zhang, G. Shuanghuanglian injection downregulates nuclear factor-kappa B expression in mice with viral encephalitis. Neural Regen. Res., 2012, 7(33), 2592-2599.
[PMID: 25368635]
[33]
Tian, Y.; Di, Z.L.; Lei, H.; Zhang, G.J.; Liang, H.D.; Chen, H.L. Experimental study on the mechanism of Shuanghuanglian injection in treating mice with viral encephalitis. J. South Med. Univ., 2009, (4), 676-679.
[34]
Li, W.; Jiang, L.M.; Guo, Y. Effect of Shuanghuanglian on coxsackie virus encephalitis model. J. Brain Nervous Dis., 2003, 34-35(1), 38.
[35]
Bigatello, L.M.; Zapol, W.M. New approaches to acute lung injury. Br. J. Anaesth., 1996, 77(1), 99-109.
[http://dx.doi.org/10.1093/bja/77.1.99] [PMID: 8703635]
[36]
Eastwood, G.L. Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N. Engl. J. Med., 2000, 343(9), 658.
[http://dx.doi.org/10.1056/NEJM200008313430912] [PMID: 10979799]
[37]
Bhatia, M.; Moochhala, S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol., 2004, 202(2), 145-156.
[http://dx.doi.org/10.1002/path.1491] [PMID: 14743496]
[38]
Zhang, H.; Chen, Q.; Zhou, W.; Gao, S.; Lin, H.; Ye, S.; Xu, Y.; Cai, J. Chinese medicine injection shuanghuanglian for treatment of acute upper respiratory tract infection: A systematic review of randomized controlled trials. Evid. Based Complement. Alternat. Med., 2013, 2013, 987326.
[http://dx.doi.org/10.1155/2013/987326] [PMID: 23606893]
[39]
Fang, L.; Gao, Y.; Liu, F.; Hou, R.; Cai, R.L.; Qi, Y. Shuang-huang-lian attenuates lipopolysaccharide-induced acute lung injury in mice involving anti-inflammatory and antioxidative activities. Evid. Based Complement. Alternat. Med., 2015, 2015, 283939.
[http://dx.doi.org/10.1155/2015/283939] [PMID: 25945107]
[40]
Gao, Y.; Fang, L.; Cai, R.; Zong, C.; Chen, X.; Lu, J.; Qi, Y. Shuang-Huang-Lian exerts anti-inflammatory and anti-oxidative activities in lipopolysaccharide-stimulated murine alveolar macrophages. Phytomedicine, 2014, 21(4), 461-469.
[http://dx.doi.org/10.1016/j.phymed.2013.09.022] [PMID: 24192210]
[41]
Brugiolo, A.S.; Alves, C.C.; Gouveia, A.C.; Dias, A.T.; Rodrigues, M.F.; Pacífico, L.G.; Aarestrup, B.J.; Machado, M.A.; Domingues, R.; Teixeira, H.C.; Gameiro, J.; Ferreira, A.P. Effects of aqueous extract of Echinodorus grandiflorus on the immune response in ovalbumin-induced pulmonary allergy. Ann. Allergy Asthma Immunol., 2011, 106(6), 481-488.
[http://dx.doi.org/10.1016/j.anai.2011.01.008] [PMID: 21624747]
[42]
Jamalkandi, S.A.; Ahmadi, A.; Ahrari, I.; Salimian, J.; Karimi, M.; Ghanei, M. Oral and nasal probiotic administration for the prevention and alleviation of allergic diseases, asthma and chronic obstructive pulmonary disease. Nutr. Res. Rev., 2021, 34(1), 1-16.
[http://dx.doi.org/10.1017/S0954422420000116] [PMID: 32281536]
[43]
Hinks, T.S.C.; Levine, S.J.; Brusselle, G.G. Treatment options in type-2 low asthma. Eur. Respir. J., 2021, 57(1), 2000528.
[http://dx.doi.org/10.1183/13993003.00528-2020] [PMID: 32586877]
[44]
Yanagisawa, R.; Koike, E.; Win-Shwe, T.T.; Ichinose, T.; Takano, H. Effects of lactational exposure to low-dose BaP on allergic and non-allergic immune responses in mice offspring. J. Immunotoxicol., 2018, 15(1), 31-40.
[http://dx.doi.org/10.1080/1547691X.2018.1442379] [PMID: 29482396]
[45]
Gao, Y.; Fei, Q.; Qi, R.; Hou, R.; Han, Y.; Cai, R.; Sun, G.; Qi, Y. Shuang-Huang-Lian attenuates airway hyperresponsiveness and inflammation in a shrimp protein induced murine asthma model. Evid. Based Complement. Alternat. Med., 2019, 2019, 4827342.
[http://dx.doi.org/10.1155/2019/4827342] [PMID: 30713573]
[46]
Zhuang, Z.; Wen, J.; Zhang, L.; Zhang, M.; Zhong, X.; Chen, H.; Luo, C. Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection? Eur. J. Integr. Med., 2020, 37, 101139.
[http://dx.doi.org/10.1016/j.eujim.2020.101139] [PMID: 32501408]
[47]
Han, R.; Ye, J.X.; Quan, L.H.; Liu, C.Y.; Yang, M.; Liao, Y.H. Evaluating pulmonary toxicity of Shuang-Huang-Lian in vitro and in vivo. J. Ethnopharmacol., 2011, 135(2), 522-529.
[http://dx.doi.org/10.1016/j.jep.2011.03.060] [PMID: 21463672]
[48]
Brzozowski, M.; Krukowska, Ż.; Galant, K.; Jursa-Kulesza, J.; Kosik-Bogacka, D. Genotypic characterisation and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of different hospitals and medical centres in Poland. BMC Infect. Dis., 2020, 20(1), 693.
[http://dx.doi.org/10.1186/s12879-020-05404-w] [PMID: 32962640]
[49]
Chan, B.K.; Stanley, G.; Modak, M.; Koff, J.L.; Turner, P.E. Bacteriophage therapy for infections in CF. Pediatr. Pulmonol., 2021, 56(Suppl. 1), S4-S9.
[http://dx.doi.org/10.1002/ppul.25190] [PMID: 33434411]
[50]
Xu, Z.; Li, K.; Pan, T.; Liu, J.; Li, B.; Li, C.; Wang, S.; Diao, Y.; Liu, X. Lonicerin, an anti-algE flavonoid against Pseudomonas aeruginosa virulence screened from Shuanghuanglian formula by molecule docking based strategy. J. Ethnopharmacol., 2019, 239, 111909.
[http://dx.doi.org/10.1016/j.jep.2019.111909] [PMID: 31026553]
[51]
Wu, S.C.; Liu, F.; Zhu, K.; Shen, J.Z. Natural products that target virulence factors in antibiotic-resistant Staphylococcus aureus. J. Agric. Food Chem., 2019, 67(48), 13195-13211.
[http://dx.doi.org/10.1021/acs.jafc.9b05595] [PMID: 31702908]
[52]
Chen, X.; Howard, O.M.; Yang, X.; Wang, L.; Oppenheim, J.J.; Krakauer, T. Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function. Life Sci., 2002, 70(24), 2897-2913.
[http://dx.doi.org/10.1016/S0024-3205(02)01541-2] [PMID: 12269401]
[53]
Su, H.X.; Yao, S.; Zhao, W.F.; Li, M.J.; Liu, J.; Shang, W.J.; Xie, H.; Ke, C.Q.; Hu, H.C.; Gao, M.N.; Yu, K.Q.; Liu, H.; Shen, J.S.; Tang, W.; Zhang, L.K.; Xiao, G.F.; Ni, L.; Wang, D.W.; Zuo, J.P.; Jiang, H.L.; Bai, F.; Wu, Y.; Ye, Y.; Xu, Y.C. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol. Sin., 2020, 41(9), 1167-1177.
[http://dx.doi.org/10.1038/s41401-020-0483-6] [PMID: 32737471]
[54]
Pan, X.; Dong, L.; Yang, L.; Chen, D.; Peng, C. Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China. Virus Res., 2020, 286, 198057.
[http://dx.doi.org/10.1016/j.virusres.2020.198057] [PMID: 32531236]
[55]
Zhang, D.H.; Wu, K.L.; Zhang, X.; Deng, S.Q.; Peng, B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med., 2020, 18(2), 152-158.
[http://dx.doi.org/10.1016/j.joim.2020.02.005] [PMID: 32113846]
[56]
Ni, L.; Zhou, L.; Zhou, M.; Zhao, J.; Wang, D.W. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19. Front. Med., 2020, 14(2), 210-214.
[http://dx.doi.org/10.1007/s11684-020-0757-x] [PMID: 32170559]
[57]
Hou, Y.C.; Lin, S.P.; Tsai, S.Y.; Ko, M.H.; Chang, Y.C.; Chao, P.D. Flavonoid pharmacokinetics and tissue distribution after repeated dosing of the roots of Scutellaria baicalensis in rats. Planta Med., 2011, 77(5), 455-460.
[http://dx.doi.org/10.1055/s-0030-1250433] [PMID: 20957598]
[58]
Zhao, T.; Tang, H.; Xie, L.; Zheng, Y.; Ma, Z.; Sun, Q.; Li, X. Scutellaria baicalensis Georgi. (Lamiaceae): A review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J. Pharm. Pharmacol., 2019, 71(9), 1353-1369.
[http://dx.doi.org/10.1111/jphp.13129] [PMID: 31236960]
[59]
Wang, Z.; Xia, Q.; Liu, X.; Liu, W.; Huang, W.; Mei, X.; Luo, J.; Shan, M.; Lin, R.; Zou, D.; Ma, Z. Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: A review. J. Ethnopharmacol., 2018, 210, 318-339.
[http://dx.doi.org/10.1016/j.jep.2017.08.040] [PMID: 28887216]
[60]
Zhou, W.; Tan, X.; Shan, J.; Liu, T.; Cai, B.; Di, L. Effect of chito-oligosaccharide on the intestinal absorptions of phenylethanoid glycosides in Fructus forsythiae extract. Phytomedicine, 2014, 21(12), 1549-1558.
[http://dx.doi.org/10.1016/j.phymed.2014.06.016] [PMID: 25442264]
[61]
Ye, J.X.; Wei, W.; Quan, L.H.; Liu, C.Y.; Chang, Q.; Liao, Y.H. An LC-MS/MS method for the simultaneous determination of chlorogenic acid, forsythiaside A and baicalin in rat plasma and its application to pharmacokinetic study of shuang-huang-lian in rats. J. Pharm. Biomed. Anal., 2010, 52(4), 625-630.
[http://dx.doi.org/10.1016/j.jpba.2010.01.035] [PMID: 20153596]
[62]
Wei-Ya, C.; Fei-Fei, Y.; Cui, L.; Wen-Hui, L.; Jie, H.; Yong-Hong, L. Comparison of plasma and pulmonary availability of chlorogenic acid, forsythiaside A and baicalin after intratracheal and intravenous administration of Shuang-Huang-Lian injection. J. Ethnopharmacol., 2021, 274, 114082.
[http://dx.doi.org/10.1016/j.jep.2021.114082] [PMID: 33813012]
[63]
Gao, R.; Lin, Y.; Liang, G.; Yu, B.; Gao, Y. Comparative pharmacokinetic study of chlorogenic acid after oral administration of Lonicerae japonicae flos and Shuang-Huang-Lian in normal and febrile rats. Phytother. Res., 2014, 28(1), 144-147.
[http://dx.doi.org/10.1002/ptr.4958] [PMID: 23447366]
[64]
Liu, R.; Lai, K.; Xiao, Y.; Ren, J. Comparative pharmacokinetics of chlorogenic acid in beagles after oral administrations of single compound, the extracts of Lonicera japanica, and the mixture of chlorogenic acid, baicalin, and Forsythia suspense. Pharm. Biol., 2017, 55(1), 1234-1238.
[http://dx.doi.org/10.1080/13880209.2017.1296002] [PMID: 28260397]
[65]
Zhou, W.; Di, L.Q.; Shan, J.J.; Bi, X.L.; Chen, L.T.; Wang, L.C. Intestinal absorption of forsythoside A in different compositions of Shuang-Huang-Lian. Fitoterapia, 2011, 82(3), 375-382.
[http://dx.doi.org/10.1016/j.fitote.2010.11.012] [PMID: 21075181]
[66]
Di, B.; Feng, N.; Liu, W. Pharmacokinetic comparisons of Shuang-Huang-Lian with the different combinations of its constitutional herbs. J. Ethnopharmacol., 2006, 107(3), 401-405.
[http://dx.doi.org/10.1016/j.jep.2006.03.030] [PMID: 16678990]
[67]
Hu, Y.; Wang, J. Interactions between clopidogrel and traditional Chinese medicine. J. Thromb. Thrombolysis, 2019, 48(3), 491-499.
[http://dx.doi.org/10.1007/s11239-019-01945-3] [PMID: 31471773]
[68]
Wang, H.; Zhang, X.; Wang, D.; Sun, H.; Lan, Y.; Jiang, H.; Chen, S.; Lin, Z. An on-line analytical approach for detecting haptens in Shuang-huang-lian powder injection. J. Chromatogr. A, 2017, 1513, 126-139.
[http://dx.doi.org/10.1016/j.chroma.2017.07.031] [PMID: 28739272]
[69]
Gu, Y.Y.; Shi, L.; Zhang, D.D.; Huang, X.; Chen, D.Z. Metabonomics delineates allergic reactions induced by Shuang-huang-lian injection in rats using ultra performance liquid chromatography-mass spectrometry. Chin. J. Nat. Med., 2018, 16(8), 628-640.
[http://dx.doi.org/10.1016/S1875-5364(18)30101-8] [PMID: 30197129]
[70]
Han, S.; Zhang, T.; Huang, J.; Cui, R.; He, L. New method of screening allergenic components from Shuanghuanglian injection: With RBL-2H3/CMC model online HPLC/MS system. J. Pharm. Biomed. Anal., 2014, 88, 602-608.
[http://dx.doi.org/10.1016/j.jpba.2013.10.006] [PMID: 24211723]
[71]
Li, Z.; Gao, Y.; Wang, H.; Liu, Z. A rat model of Shuang Huang Lian injection-induced anaphylaxis. Asian Pac. J. Allergy Immunol., 2010, 28(2-3), 185-191.
[PMID: 21038789]
[72]
Li, Y.; Xu, C.; Wang, H.; Liu, X.; Jiang, L.; Liang, S.; Wu, Z.; Wang, Z.; Zhou, J.; Xiao, W.; Guo, Z.; Wang, Y. Systems pharmacology reveals the multi-level synergetic mechanism of action of Ginkgo biloba L. leaves for cardiomyopathy treatment. J. Ethnopharmacol., 2021, 264, 113279.
[http://dx.doi.org/10.1016/j.jep.2020.113279] [PMID: 32810617]
[73]
Chen, H.; Min, J.; Li, W.; Zhao, W.; Mi, S.; Wang, N.; Zhu, C. The pharmacokinetics change of cefepime after Shuanghuanglian injection administration in subjects with the renal damage. Drug Chem. Toxicol., 2016, 39(2), 129-136.
[http://dx.doi.org/10.3109/01480545.2015.1053565] [PMID: 26108148]
[74]
Ramaiah, B.; Nagaraja, S.H.; Kapanigowda, U.G.; Boggarapu, P.R.; Subramanian, R. High azithromycin concentration in lungs by way of bovine serum albumin microspheres as targeted drug delivery: Lung targeting efficiency in albino mice. Daru, 2016, 24(1), 14.
[http://dx.doi.org/10.1186/s40199-016-0153-x] [PMID: 27150818]
[75]
Salman, S.; Davis, T.M.; Page-Sharp, M.; Camara, B.; Oluwalana, C.; Bojang, A.; D’Alessandro, U.; Roca, A. Pharmacokinetics of transfer of azithromycin into the breast milk of African mothers. Antimicrob. Agents Chemother., 2015, 60(3), 1592-1599.
[http://dx.doi.org/10.1128/AAC.02668-15] [PMID: 26711756]
[76]
Tian, J.; Sun, S.; Zhao, Z.; Li, X. Pharmacokinetic interaction between shuanghuanglian and azithromycin injection: A nonlinear mixed-effects model analysis in rats. Xenobiotica, 2019, 49(11), 1344-1351.
[http://dx.doi.org/10.1080/00498254.2018.1550588] [PMID: 30457423]
[77]
Yıldırım, S.; Karakoç, H.N.; Yaşar, A.; Köksal, İ. Determination of levofloxacin, ciprofloxacin, moxifloxacin and gemifloxacin in urine and plasma by HPLC-FLD-DAD using pentafluorophenyl core-shell column: Application to drug monitoring. Biomed. Chromatogr., 2020, 34(10), e4925.
[http://dx.doi.org/10.1002/bmc.4925] [PMID: 32557742]
[78]
Ye, J.; Song, X.; Liu, Z.; Zhao, X.; Geng, L.; Bi, K.; Chen, X. Development of an LC-MS method for determination of three active constituents of Shuang-huang-lian injection in rat plasma and its application to the drug interaction study of Shuang-huang-lian freeze-dried powder combined with levofloxacin injection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2012, 898, 130-135.
[http://dx.doi.org/10.1016/j.jchromb.2012.04.036] [PMID: 22608805]
[79]
Xiao, P.; Hou, L.; Liu, Z.; Mu, Y.; Liu, Z.; Wang, J.; Qiu, S. Animal models for analysis of hypersensitivity reactions to Shuanghuanglian injection. Mol. Immunol., 2020, 122(122), 62-68.
[http://dx.doi.org/10.1016/j.molimm.2020.03.014] [PMID: 32302806]

Rights & Permissions Print Cite
Article Metrics
39
1
World Chagas Disease
© 2024 Bentham Science Publishers | Privacy Policy